OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of
digital health solutions for life science companies and payers,
announced that Michigan-based clinic, True™ Women’s Health, has
launched a new health app powered by the company’s RMDY digital
health tools.
The app focuses on delivering virtual care and patient support,
and enables the clinic to treat patients nationwide with
personalized health and wellness programs during the COVID-19
pandemic.
“OptimizeRx’s RMDY digital health tools empowered us to launch
our practice virtually during the COVID-19 crisis, and
particularly to help manage menopause, which is a complicated
health process and the most dramatic risk factor for heart disease
in women,” said Dr. Diana Bitner, chief medical officer and
co-founder of True Women’s Health. “The ability to have a virtual
care platform supported by our team and proprietary whole-health
program has been tremendous for us to stay on schedule with the
launch of our clinic, even when our physical location is delayed
due to COVID-19.”
“By combining the power of technology and medicine,” continued
Bitner,” we can provide personalized support programs paired with
physician telehealth visits that help patients manage the symptoms
of menopause and stay on track for healthy aging.”
The True Women’s Health app guides patients through a
personalized patient journey that includes educational videos,
trackers, surveys, direct coaching and telehealth consults, as well
as easy appointment scheduling for both patient and provider. They
can also track progress against program goals throughout the year
and discuss health information during virtual visits. Patients can
track their menopause symptoms and connect their occurrence to
their daily activities, which gives providers specific data to
support an individualized care plan.
“Patient engagement and telehealth are more than about virtual
visits,” noted OptimizeRx’s vice president of customer strategy and
engagement, Rebecca Love, RN, MSN. “Our RMDY digital health tools
enable Dr. Bitner and other healthcare providers to have
touchpoints with their patients throughout the year, increasing
adherence and creating better outcomes. This is the future of
healthcare.”
OptimizeRx’s RMDY digital health tools are proven to drive
positive, measurable behavior change across a variety of health
management programs by helping patients efficiently track and
manage their habits with the goal of improving personal health. In
addition to women’s health, the virtual care solution has been
applied to mental health services, cardiac rehabilitation, chronic
condition management and diabetes prevention. The solution is part
of OptimizeRx’s comprehensive digital health program designed for
providers, health plans, life science companies and other
healthcare organizations.
To receive more information about RMDY digital health tools or
to schedule a demo, submit your request here. The True Women’s
Health app is available for download today from the Apple App store
or Google Play store.
About True Women’s HealthTrue Women’s Health is
a concierge clinic providing a total wellness experience for women.
The clinic specializes in women’s health with an expertise in
midlife, menopause, and sexual health. It offers a high-touch
personalized care approach that addresses each woman’s individual
needs. It aims to educate women at every age about their wellness
while driving prevention, individualized goal setting, and health
planning. True Women’s Health was founded by OB/GYN Diana Bitner,
M.D., who is a North American Menopause Society Certified Menopause
Practitioner (NAMS) and has more than 28 years of experience
serving thousands of women across West Michigan. The midlife,
menopause, and sexual health wellness clinic will be located at
2144 E. Paris Ave., Grand Rapids, Michigan. For more information,
visit www.truewomenshealth.com.
About OptimizeRx® OptimizeRx Corporation
(NASDAQ: OPRX) is a digital health company that facilitates
communication at point-of-care among all stakeholders in
healthcare. Primarily focused on life science and payer clients,
its suite of digital and mobile SaaS-based solutions enables
affordability, patient adherence and care management. OptimizeRx’s
network reaches more than 60% of U.S. ambulatory providers,
delivering therapeutic support on specialty medications and patient
financial assistance directly within a provider’s workflow through
leading electronic health platforms. OptimizeRx’s fully integrated
platform supports the real-time exchange of information, improving
provider knowledge and patient engagement, and ultimately leading
to healthier outcomes.
For more information, follow the company on Twitter, LinkedIn or
visit www.OptimizeRx.com.
Important Cautions Regarding Forward Looking
Statements This press release contains forward-looking
statements within the definition of Section 27A of the Securities
Act of 1933, as amended, and such as in section 21E of the
Securities Act of 1934, as amended. These forward-looking
statements should not be used to make an investment decision. The
words 'estimate,' 'possible' and 'seeking' and similar expressions
identify forward-looking statements, which speak only as to the
date the statement was made. The company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition, and other material
risks.
Trademarks are the property of their respective owners.
OptimizeRx Contact Doug Baker, CFO Tel
(248) 651-6568 x807 dbaker@optimizerx.com
Media Relations Contact Maira Alejandra,
Media Relations Manager Tel (754) 245-7070
malejandra@optimizerx.com
Investor Relations Contact Ron Both or
Grant StudeCMA Investor RelationsTel (949) 432-7557
oprx@cma.team
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/a9b8a323-b5b0-4d7e-b128-e7d2fbef5f8d
OptimizeRx (NASDAQ:OPRX)
過去 株価チャート
から 9 2024 まで 10 2024
OptimizeRx (NASDAQ:OPRX)
過去 株価チャート
から 10 2023 まで 10 2024